Stereotactic Radiosurgery for Acoustic Neuroma: A Canadian Perspective

Stereotactically delivered radiation is now an accepted treatment for patients with acoustic neuroma. In some cases, patient preference may be the reason for its selection, while in others neurosurgeons may select it for patients who are elderly or have significant risk factors for conventional surg...

Full description

Saved in:
Bibliographic Details
Published in:Canadian journal of neurological sciences 1998-11, Vol.25 (4), p.310-314
Main Authors: Ross, Ian B., Tator, Charles H.
Format: Article
Language:English
Subjects:
Biological and medical sciences
Canada
Ear, auditive nerve, cochleovestibular tract, facial nerve: diseases, semeiology
Health Care Costs
Humans
Medical sciences
Neuroma, Acoustic - surgery
Original Articles
Otorhinolaryngology. Stomatology
Radiosurgery - economics
Stereotaxic Techniques - economics
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Stereotactically delivered radiation is now an accepted treatment for patients with acoustic neuroma. In some cases, patient preference may be the reason for its selection, while in others neurosurgeons may select it for patients who are elderly or have significant risk factors for conventional surgery. The majority of patients with acoustic neuroma treatment with stereotactic radiosurgery have been treated with the Gamma Knife, with follow ups of over 25 years in some instances. Other radiosurgical modalities utilizing the linear accelerator have been developed and appear promising, but there is no long-term follow up. Canada does not possess a Gamma Knife facility, and its government-funded hospital and medical insurance agencies have made it difficult for patients to obtain reimbursement for Gamma Knife treatments in other countries. We review the literature to date on the various forms of radiation treatment for acoustic neuroma and discuss the current issues facing physicians and patients in Canada who wish to obtain their treatment of choice.
ISSN:0317-1671
2057-0155
DOI:10.1017/S0317167100034338